Interestingly, our results revealed the highly up-regulated SLC35A2 expression in STAD tissues with TP53 mutation compared to those without TP53 mutation, which suggests that SLC35A2 may be involved in the carcinogenesis process of the TP53 pathway. The gene discussed is TP53; the disease is gastric adenocarcinoma.